3998-88-7 Usage
General Description
Ethyl 2-chloro-6-methylpyridine-4-carboxylate, 97% is a chemical compound that is composed of ethyl, chlorine, methyl, and carboxylate groups. It is a 97% pure form of the compound, with the remaining 3% consisting of impurities. Ethyl 2-chloro-6-methylpyridine-4-carboxylate, 97% is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. It is a highly reactive compound that is used as a building block in the production of various organic molecules. Its specific properties and reactivity make it valuable in the development and production of a wide range of chemical products.
Check Digit Verification of cas no
The CAS Registry Mumber 3998-88-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,9,9 and 8 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 3998-88:
(6*3)+(5*9)+(4*9)+(3*8)+(2*8)+(1*8)=147
147 % 10 = 7
So 3998-88-7 is a valid CAS Registry Number.
InChI:InChI=1/C9H10ClNO2/c1-3-13-9(12)7-4-6(2)11-8(10)5-7/h4-5H,3H2,1-2H3
3998-88-7Relevant articles and documents
2-(1H-pyrazol-3-yl) pyridine derivative as well as preparation method and application thereof
-
Paragraph 0071-0074, (2021/06/22)
The invention belongs to the field of medicinal chemistry, particularly relates to a compound shown in a formula I, or a stereoisomer, salt, prodrug or solvate thereof, and also relates to a preparation method of the compound and application of the compound in preparation of drugs for treating related diseases mediated by histone demethylase JMJD6.
NOVEL PYRIMIDINE-PYRIDINE DERIVATIVES
-
Page/Page column 17, (2011/04/14)
The invention relates to novel pyrimidine-pyridine derivatives, their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunomodulating agents.
3-AZA-BICYCLO[3.1.0]HEXANE DERIVATIVES
-
Page/Page column 58, (2010/02/17)
The invention relates to 3-aza-bicyclo[3.1.0]hexane derivatives of formula (I) wherein A, B, n, X, and R1 are as described in the description, and salts thereof, and their use as orexin receptor antagonists.